13F Holdings
中文EN

UEEC United Health Products, Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1096938 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY52.1%
TTM EPS YoY100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-863.4%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets1,891.6%
Debt / equity—
Current ratio0.02x
Interest coverage-5.60x

Cash quality & payout

Operating cash flow / net income0.67x
Accruals ratio-286.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$0$0$0$37,500$59
Cost of revenue——$0$18,644$25
Gross profit——$0$18,856$34
R&D expense$269,867$355,936$598,810$624,564$237,458
SG&A expense$1.99M$1.65M$1.83M$2.20M$29.56M
Operating income-$2.26M-$2.01M-$2.43M-$2.80M-$29.80M
Interest expense$113,284$32,322$32,875$17,022$226,139
Income tax$0$0$0$0$0
Net income-$2.67M-$2.00M-$2.62M-$1.69M-$30.55M
EBITDA-$2.25M-$2.00M-$2.42M-$2.80M-$29.80M
EPS (diluted)-0.01-0.01-0.01——
Weighted avg. shares (diluted)256.98M248.17M239.08M——
Balance sheet
Cash & equivalents$65,249$168,883$95,420$13,377$21,799
Inventory—$0$33,598$34,730$0
Current assets$105,392$191,683$151,822$71,039$26,799
PP&E, net————$0
Intangibles$24,300$28,350$32,400$36,450$0
Total assets$316,698$269,979$284,643$350,528$26,799
Current liabilities$4.05M$1.64M$1.95M$2.42M$1.17M
Total liabilities$4.30M$2.71M$2.00M$2.42M$1.17M
Shareholders' equity-$3.98M-$2.46M-$1.71M-$2.06M-$1.14M
Shares outstanding258.69M252.41M244.78M230.87M228.67M
Cash flow statement
Operating cash flow-$1.19M-$1.19M-$2.20M-$619,720-$828,079
Capital expenditure————$0
Free cash flow————-$828,079
Investing cash flow$0$0-$2,850-$40,500$0
Financing cash flow$1.08M$1.27M$2.29M$651,798$803,802
Depreciation & amortization$4,050$4,050$4,050$4,050$4,050
Stock-based compensation———$483,450$26.86M
Share buybacks——$0$50,000—

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.